Noonan Syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Noonan Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
"PTPN11 gene mutations: linking the Gln510Glu mutation to the ""LEOPARD syndrome phenotype""."
|
16733669 |
2006 |
Noonan Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
12 prepubertal children with Noonan syndrome due to mutations in the PTPN11 gene [7 males, 6 females; median age, years: 8.6 (range 5.1-13.4)] were studied; 12 prepubertal children with short stature (SS) [7 males, 5 females; median age, years: 8.1 (range 4.8-13.1)] served as the control group.
|
23624134 |
2013 |
Noonan Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Noonan syndrome type I with PTPN11 3 bp deletion: structure-function implications.
|
15521065 |
2005 |
Noonan Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Noonan syndrome (NS) is an autosomal dominant disorder caused by mutations in PTPN11, KRAS, SOS1, and RAF1.
|
19953625 |
2010 |
Noonan Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Noonan syndrome: Severe phenotype and PTPN11 mutations.
|
29703613 |
2019 |
Noonan Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Noonan syndrome (NS) is caused by mutations in more than 10 genes, mainly PTPN11, SOS1, RAF1, and RIT1.
|
31368652 |
2019 |
Noonan Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
PTPN11 mutation in a large family with Noonan syndrome and dizygous twinning.
|
12529711 |
2003 |
Noonan Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
PTPN11 mutation in a large family with Noonan syndrome and dizygous twinning.
|
12529711 |
2003 |
Noonan Syndrome
|
1.000 |
Biomarker
|
disease |
CLINGEN |
PTPN11 mutation in a large family with Noonan syndrome and dizygous twinning.
|
12529711 |
2003 |
Noonan Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
SHP-2 is required during development, and germline mutations in PTPN11, the gene encoding SHP-2, cause Noonan syndrome.
|
14982869 |
2004 |
Noonan Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
PTPN11, encoding SHP-2, is the first identified gene for Noonan syndrome and also the first identified proto-oncogene that encodes a tyrosine phosphatase.
|
18758896 |
2008 |
Noonan Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
PTPN11 analysis for the prenatal diagnosis of Noonan syndrome in fetuses with abnormal ultrasound findings.
|
18759865 |
2009 |
Noonan Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
PTPN11 gene mutations were described in several individuals with this phenotype, and it is recently considered as a variant phenotype of NS.
|
19438935 |
2009 |
Noonan Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
PTPN11 mutation associated with aortic dilation and hypertrophic cardiomyopathy in a pediatric patient with Noonan syndrome.
|
19795160 |
2010 |
Noonan Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
PTPN11 (39.0%), SOS1 (20.3%), RAF1 (6.8%), KRAS (5.1%), and BRAF (1.7%) mutations were identified in NS; BRAF (41.2%), SHOC2 (23.5%), and MEK1 (5.9%) mutations in cardiofaciocutaneous syndrome; and HRAS and PTPN11 mutations in Costello syndrome and LEOPARD syndrome, respectively.
|
21784453 |
2011 |
Noonan Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
PTPN11 mutations cause LEOPARD syndrome (LS) and Noonan syndrome (NS), two disorders that are part of a newly classified family of autosomal dominant syndromes termed "RASopathies," which are caused by germline mutations in components of the RAS/RAF/MEK/ERK mitogen activating protein kinase pathway.
|
22681964 |
2011 |
Noonan Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Shp2 is a classical non-receptor protein tyrosine phosphatase (PTP) involved in many human diseases such as Noonan syndrome and tumors, and identified as a potential therapeutic target.
|
27939989 |
2017 |
Noonan Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
PTPN11 mutation accounts for 64.7% of cases with clinical features of Noonan syndrome in India.
|
28607217 |
2017 |
Noonan Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
PTPN11 was also the most frequently detected mutation in patients with NS and NSRD.
|
31837205 |
2020 |
Noonan Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
A PTPN11 gene mutation was identified in 104 (38.25%) of 274 patients with Noonan syndrome.Heart defect was present in 85%.
|
17515436 |
2007 |
Noonan Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
A de novo T73I mutation in PTPN11 in a neonate with severe and prolonged congenital thrombocytopenia and Noonan syndrome.
|
23446178 |
2013 |
Noonan Syndrome
|
1.000 |
Biomarker
|
disease |
CLINGEN |
A de novo T73I mutation in PTPN11 in a neonate with severe and prolonged congenital thrombocytopenia and Noonan syndrome.
|
23446178 |
2013 |
Noonan Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
A germline gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells.
|
20651068 |
2010 |
Noonan Syndrome
|
1.000 |
Biomarker
|
disease |
CLINGEN |
A mother and son with Noonan syndrome resulting from a PTPN11 mutation: first report of molecularly proven cases from Turkey.
|
20718194 |
2010 |